These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34776434)

  • 1. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    Pavlik VN; Burnham SC; Kass JS; Helmer C; Palmqvist S; Vassilaki M; Dartigues JF; Hansson O; Masters CL; Pérès K; Petersen RC; Stomrud E; Butler L; Coloma PM; Teitsma XM; Doody R; Sano M;
    J Alzheimers Dis; 2022; 85(1):31-45. PubMed ID: 34776434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol.
    König A; Linz N; Baykara E; Tröger J; Ritchie C; Saunders S; Teipel S; Köhler S; Sánchez-Benavides G; Grau-Rivera O; Gispert JD; Palmqvist S; Tideman P; Hansson O
    J Prev Alzheimers Dis; 2023; 10(2):314-321. PubMed ID: 36946458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote evaluation of sleep to enhance understanding of early dementia due to Alzheimer's Disease (RESTED-AD): an observational cohort study protocol.
    Blackman J; Morrison HD; Gabb V; Biswas B; Li H; Turner N; Jolly A; Trender W; Hampshire A; Whone A; Coulthard E
    BMC Geriatr; 2023 Sep; 23(1):590. PubMed ID: 37742001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.
    Koychev I; Lawson J; Chessell T; Mackay C; Gunn R; Sahakian B; Rowe JB; Thomas AJ; Rochester L; Chan D; Tom B; Malhotra P; Ballard C; Chessell I; Ritchie CW; Raymont V; Leroi I; Lengyel I; Murray M; Thomas DL; Gallacher J; Lovestone S
    BMJ Open; 2019 Mar; 9(3):e024498. PubMed ID: 30904851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy.
    Udeh-Momoh CT; Watermeyer T; Price G; de Jager Loots CA; Reglinska-Matveyev N; Ropacki M; Ketter N; Fogle M; Raghavan N; Arrighi M; Brashear R; Di J; Baker S; Giannakopoulou P; Robb C; Bassil D; Cohn M; McLellan-Young H; Crispin J; Lakey K; Lisa C; Chowdary Seemulamoodi Y; Kafetsouli D; Perera D; Car J; Majeed A; Ward H; Ritchie K; Perneczky R; Kivipelto M; Scott D; Bracoud L; Saad Z; Novak G; Ritchie CW; Middleton L
    BMJ Open; 2021 Jun; 11(6):e043114. PubMed ID: 34168021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
    de Erausquin GA; Snyder H; Brugha TS; Seshadri S; Carrillo M; Sagar R; Huang Y; Newton C; Tartaglia C; Teunissen C; Håkanson K; Akinyemi R; Prasad K; D'Avossa G; Gonzalez-Aleman G; Hosseini A; Vavougios GD; Sachdev P; Bankart J; Mors NPO; Lipton R; Katz M; Fox PT; Katshu MZ; Iyengar MS; Weinstein G; Sohrabi HR; Jenkins R; Stein DJ; Hugon J; Mavreas V; Blangero J; Cruchaga C; Krishna M; Wadoo O; Becerra R; Zwir I; Longstreth WT; Kroenenberg G; Edison P; Mukaetova-Ladinska E; Staufenberg E; Figueredo-Aguiar M; Yécora A; Vaca F; Zamponi HP; Re VL; Majid A; Sundarakumar J; Gonzalez HM; Geerlings MI; Skoog I; Salmoiraghi A; Boneschi FM; Patel VN; Santos JM; Arroyo GR; Moreno AC; Felix P; Gallo C; Arai H; Yamada M; Iwatsubo T; Sharma M; Chakraborty N; Ferreccio C; Akena D; Brayne C; Maestre G; Blangero SW; Brusco LI; Siddarth P; Hughes TM; Zuñiga AR; Kambeitz J; Laza AR; Allen N; Panos S; Merrill D; Ibáñez A; Tsuang D; Valishvili N; Shrestha S; Wang S; Padma V; Anstey KJ; Ravindrdanath V; Blennow K; Mullins P; Łojek E; Pria A; Mosley TH; Gowland P; Girard TD; Bowtell R; Vahidy FS
    Alzheimers Dement (N Y); 2022; 8(1):e12348. PubMed ID: 36185993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
    Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
    BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
    Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
    J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research.
    Stites SD; Coe NB
    J Alzheimers Dis; 2023; 92(3):729-740. PubMed ID: 36806503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.
    Dienemann T; Fujii N; Orlandi P; Nessel L; Furth SL; Hoy WE; Matsuo S; Mayer G; Methven S; Schaefer F; Schaeffner ES; Solá L; Stengel B; Wanner C; Zhang L; Levin A; Eckardt KU; Feldman HI
    BMC Nephrol; 2016 Sep; 17(1):121. PubMed ID: 27590182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
    Assunção SS; Sperling RA; Ritchie C; Kerwin DR; Aisen PS; Lansdall C; Atri A; Cummings J
    Alzheimers Res Ther; 2022 Apr; 14(1):54. PubMed ID: 35440022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.